跳至主要内容
临床试验/CTRI/2026/07/113629
CTRI/2026/07/113629进行中(未招募)2/3 期

A randomized clinical trial to evaluate the efficacy of Champakadi Agad orally in the management of Dushivishajanya Sheetapitta (Urticaria) in comparison with Haridra khanda - Nil

Sane Guruji Arogya Kendra0 个研究点目标入组 30 人开始时间: 2026年7月27日最近更新:

试验速览

阶段
2/3 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The study will enroll individuals diagnosed with sheetapitta exhibiting classical features along with signs of Dushivisha regardless of their gender occupation socioeconomic background religion.
  • Participants should be between 19 and 60 years of age.
  • Cases with chronic more than 6 weeksor recurrent Sheetpitta indicating possible
  • Dushivisha association will be included.
  • Participants must consent to take part and share necessary information for the

排除标准

  • Pregnant and lactating women
  • Acute severe systemic illness
  • Known hypersensitivity to study drugs
  • Concurrent use of antihistamines corticosteroids unwilling to continue

研究者

相似试验